Tandem Diabetes Care, Inc. (TNDM)
USD 21.48
(7.51%)
USD 21.48
(7.51%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 415.66 Million USD | -1.0% |
| 2022 | 419.87 Million USD | 33.43% |
| 2021 | 314.66 Million USD | 37.82% |
| 2020 | 228.31 Million USD | 1020.14% |
| 2019 | 20.38 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 76.54 Million USD | -3.06% |
| 2016 | 78.96 Million USD | 166.14% |
| 2015 | 29.66 Million USD | 0.78% |
| 2014 | 29.44 Million USD | 0.15% |
| 2013 | 29.39 Million USD | 599.39% |
| 2012 | 4.2 Million USD | -67.31% |
| 2011 | 12.85 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 477.54 Million USD | 14.89% |
| 2024 Q2 | 477.11 Million USD | -0.09% |
| 2023 Q4 | 415.66 Million USD | -0.61% |
| 2023 Q3 | 418.21 Million USD | -0.49% |
| 2023 FY | 415.66 Million USD | -1.0% |
| 2023 Q1 | 420.39 Million USD | 0.12% |
| 2023 Q2 | 420.28 Million USD | -0.03% |
| 2022 FY | 419.87 Million USD | 33.43% |
| 2022 Q4 | 419.87 Million USD | -0.51% |
| 2022 Q1 | 419.18 Million USD | 33.21% |
| 2022 Q3 | 422.01 Million USD | -0.01% |
| 2022 Q2 | 422.07 Million USD | 0.69% |
| 2021 FY | 314.66 Million USD | 37.82% |
| 2021 Q2 | 317.23 Million USD | -0.44% |
| 2021 Q1 | 318.62 Million USD | 39.55% |
| 2021 Q4 | 314.66 Million USD | -0.41% |
| 2021 Q3 | 315.97 Million USD | -0.4% |
| 2020 Q4 | 228.31 Million USD | 0.86% |
| 2020 Q3 | 226.37 Million USD | 1.84% |
| 2020 Q1 | 27.86 Million USD | 36.72% |
| 2020 Q2 | 222.28 Million USD | 697.65% |
| 2020 FY | 228.31 Million USD | 1020.14% |
| 2019 Q4 | 20.38 Million USD | -3.89% |
| 2019 Q3 | 21.2 Million USD | -3.37% |
| 2019 FY | 20.38 Million USD | 0.0% |
| 2019 Q1 | 14.38 Million USD | 0.0% |
| 2019 Q2 | 21.94 Million USD | 52.55% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | 76.4 Million USD | -0.18% |
| 2018 Q2 | 77.1 Million USD | 0.91% |
| 2017 FY | 76.54 Million USD | -3.06% |
| 2017 Q4 | 76.54 Million USD | 1.25% |
| 2017 Q1 | 73.76 Million USD | -6.58% |
| 2017 Q3 | 75.59 Million USD | 1.23% |
| 2017 Q2 | 74.67 Million USD | 1.24% |
| 2016 Q1 | 44.1 Million USD | 48.66% |
| 2016 FY | 78.96 Million USD | 166.14% |
| 2016 Q4 | 78.96 Million USD | 76.72% |
| 2016 Q3 | 44.68 Million USD | 0.64% |
| 2016 Q2 | 44.39 Million USD | 0.66% |
| 2015 FY | 29.66 Million USD | 0.78% |
| 2015 Q4 | 29.66 Million USD | 0.58% |
| 2015 Q3 | 29.49 Million USD | 0.07% |
| 2015 Q2 | 29.47 Million USD | 0.07% |
| 2015 Q1 | 29.45 Million USD | 0.06% |
| 2014 Q1 | 29.44 Million USD | 0.16% |
| 2014 FY | 29.44 Million USD | 0.15% |
| 2014 Q4 | 29.44 Million USD | 0.08% |
| 2014 Q3 | 29.41 Million USD | 0.08% |
| 2014 Q2 | 29.39 Million USD | -0.18% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | 29.29 Million USD | 0.0% |
| 2013 Q3 | 29.34 Million USD | 0.19% |
| 2013 Q4 | 29.39 Million USD | 0.16% |
| 2013 FY | 29.39 Million USD | 599.39% |
| 2012 FY | 4.2 Million USD | -67.31% |
| 2012 Q4 | 4.2 Million USD | 0.0% |
| 2011 FY | 12.85 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| electroCore, Inc. | 626 Thousand USD | -66300.479% |
| NeuroPace, Inc. | 72.39 Million USD | -474.165% |
| Sight Sciences, Inc. | 35.41 Million USD | -1073.736% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -25960.627% |
| SI-BONE, Inc. | 38.99 Million USD | -966.031% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -1331.508% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -959.834% |
| Cerus Corporation | 95.99 Million USD | -332.991% |
| Axonics, Inc. | 27.61 Million USD | -1405.113% |
| 908 Devices Inc. | 5.94 Million USD | -6891.876% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -491.251% |
| TELA Bio, Inc. | 42.78 Million USD | -871.639% |
| Venus Concept Inc. | 79.69 Million USD | -421.559% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -112546.883% |
| RxSight, Inc. | 3.01 Million USD | -13700.365% |
| LENSAR, Inc. | 2.3 Million USD | -17902.036% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -5558.413% |
| LivaNova PLC | 640.4 Million USD | 35.093% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -17603.024% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -2624.792% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 23.263% |
| Apyx Medical Corporation | 38.5 Million USD | -979.627% |
| Cutera, Inc. | 431.91 Million USD | 3.761% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -2558.907% |
| BioSig Technologies, Inc. | 452 Thousand USD | -91861.726% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 75.283% |
| Bioventus Inc. | 409.47 Million USD | -1.512% |
| Envoy Medical, Inc. | 404 Thousand USD | -102787.871% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -729140.351% |
| Outset Medical, Inc. | 136.18 Million USD | -205.216% |
| Nexalin Technology, Inc. | 4463.00 USD | -9313523.123% |
| IRIDEX Corporation | 2.74 Million USD | -15037.181% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -424.806% |
| IRadimed Corporation | 2.04 Million USD | -20245.485% |
| PAVmed Inc | 48.72 Million USD | -753.088% |
| INVO Bioscience, Inc. | 8.68 Million USD | -4686.827% |
| Movano Inc. | 252 Thousand USD | -164847.222% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -1152.99% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -225315.944% |
| Spectral AI, Inc. | 1.28 Million USD | -32147.246% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -3946.926% |
| Varex Imaging Corporation | 469.5 Million USD | 11.466% |
| Quipt Home Medical Corp. | 98.94 Million USD | -320.105% |
| IceCure Medical Ltd | 599 Thousand USD | -69293.489% |
| Pulmonx Corporation | 41.42 Million USD | -903.445% |
| Modular Medical, Inc. | 1.19 Million USD | -34830.0% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -158551.527% |
| Insulet Corporation | 1.44 Billion USD | 71.31% |
| Semler Scientific, Inc. | 70 Thousand USD | -593710.0% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -2881.615% |
| Orthofix Medical Inc. | 134.19 Million USD | -209.739% |
| InMode Ltd. | 9.01 Million USD | -4509.815% |
| Bruker Corporation | 1.37 Billion USD | 69.87% |
| Surmodics, Inc. | 29.4 Million USD | -1313.593% |
| Cytosorbents Corporation | 18.31 Million USD | -2169.773% |
| iCAD, Inc. | 461 Thousand USD | -90066.377% |
| DexCom, Inc. | 2.59 Billion USD | 83.976% |
| Align Technology, Inc. | 96.96 Million USD | -328.664% |
| ZimVie Inc. | 521.92 Million USD | 20.36% |
| Nexalin Technology, Inc. | 4463.00 USD | -9313523.123% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -20719.785% |
| BrainsWay Ltd. | 471 Thousand USD | -88152.017% |
| Profound Medical Corp. | 7.9 Million USD | -5161.361% |
| enVVeno Medical Corporation | 1.4 Million USD | -29548.146% |
| Nuwellis, Inc. | 981 Thousand USD | -42271.764% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -4850.774% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -44105.033% |
| Inogen, Inc. | 21.92 Million USD | -1796.032% |
| MaxCyte, Inc. | 18.74 Million USD | -2117.719% |
| iRhythm Technologies, Inc. | 129.82 Million USD | -220.177% |
| OrthoPediatrics Corp. | 23.76 Million USD | -1649.44% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -20719.785% |
| InspireMD, Inc. | 1.59 Million USD | -25960.627% |
| PAVmed Inc. | 48.72 Million USD | -753.088% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -84386.708% |
| BIOLASE, Inc. | 17.91 Million USD | -2220.865% |
| Beyond Air, Inc. | 17.83 Million USD | -2230.364% |
| FONAR Corporation | 41.67 Million USD | -897.381% |
| AxoGen, Inc. | 69.29 Million USD | -499.877% |
| Vivani Medical, Inc. | 20.69 Million USD | -1908.441% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -725.145% |
| Inari Medical, Inc. | 32.04 Million USD | -1197.054% |
| UFP Technologies, Inc. | 46.03 Million USD | -802.898% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -13434.96% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -40009.211% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -13799.271% |
| Tenon Medical, Inc. | 1.17 Million USD | -35336.232% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -41383.733% |
| CVRx, Inc. | 30.61 Million USD | -1257.812% |
| AdaptHealth Corp. | 2.29 Billion USD | 81.885% |
| Sintx Technologies, Inc. | 4.24 Million USD | -9691.92% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -20735.439% |
| NanoVibronix, Inc. | 5000.00 USD | -8313240.0% |
| Quanterix Corporation | 41.46 Million USD | -902.477% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -17603.024% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -52986.462% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 55.493% |
| TransMedics Group, Inc. | 515.94 Million USD | 19.436% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -21742.722% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -172464.722% |
| Hyperfine, Inc. | 185 Thousand USD | -224584.865% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | -116.241% |
| Biomerica, Inc. | 785 Thousand USD | -52851.21% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -92376.69% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -112210.561% |
| Silk Road Medical, Inc | 84.63 Million USD | -391.141% |